BBIO vs NTRS

Comparison between BridgeBio Pharma Inc (BBIO, Company) and Northern Trust Corp (NTRS, Company).

BBIO is from the Healthcare sector, while NTRS is from the Financial Services sector.

5-Year PerformanceNTRS has outperformed BBIO, delivering a return of +13.1% compared to +8.9%

BBIO vs NTRS - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	BBIO(COMPANY)	NTRS(COMPANY)
Market Cap	$16B	$34B
Max Drawdown	92.80%	68.66%
Sharpe Ratio	1.24	1.61
5Y Beta	1.02	1.02
Industry	Biotechnology	Asset Management
P/E Ratio	-21.74	15.25
Forward P/E	N/A	16.89
PEG Ratio	-3.88	0.42
Dividend Yield	N/A	1.75%
5Y Dividends CAGR	N/A	7.12%
5Y EPS CAGR	-3.14%	14.51%
Debt to Equity	-116.44%	0.00%
Free Cash Flow Yield	-2.77%	1.32%
P/S Ratio	27.69	3.71
P/B Ratio	123.68	2.67

Market Cap

BBIO

$16B

Winner

NTRS

$34B

Max Drawdown

BBIO

92.80%

Winner

NTRS

68.66%

Sharpe Ratio

BBIO

1.24

Winner

NTRS

1.61

5Y Beta

Winner

BBIO

1.02

NTRS

1.02

Industry

BBIO

Biotechnology

NTRS

Asset Management

P/E Ratio

Winner

BBIO

-21.74

NTRS

15.25

Forward P/E

BBIO

N/A

NTRS

16.89

PEG Ratio

Winner

BBIO

-3.88

NTRS

0.42

Dividend Yield

BBIO

N/A

NTRS

1.75%

5Y Dividends CAGR

BBIO

N/A

NTRS

7.12%

5Y EPS CAGR

BBIO

-3.14%

Winner

NTRS

14.51%

Debt to Equity

Winner

BBIO

-116.44%

NTRS

0.00%

Free Cash Flow Yield

BBIO

-2.77%

Winner

NTRS

1.32%

P/S Ratio

BBIO

27.69

Winner

NTRS

3.71

P/B Ratio

BBIO

123.68

Winner

NTRS

2.67

BBIO vs NTRS - Historical Returns

Returns include dividend reinvestment.

Period	BBIO	NTRS
1 month	+6.50%	+1.66%
3 months	+21.60%	+13.30%
6 months	+21.68%	+22.30%
1 year	+84.78%	+49.89%
5 years(CAGR)	+8.89%	+13.15%
10 years(CAGR)	N/A	+13.34%
Max(CAGR)	+16.74%	+7.40%

Winner

BBIO

+6.50%

NTRS

+1.66%

Winner

BBIO

+21.60%

NTRS

+13.30%

BBIO

+21.68%

Winner

NTRS

+22.30%

Winner

BBIO

+84.78%

NTRS

+49.89%

5Y(CAGR)

BBIO

+8.89%

Winner

NTRS

+13.15%

10Y(CAGR)

BBIO

N/A

NTRS

+13.34%

Max(CAGR)

Winner

BBIO

+16.74%

NTRS

+7.40%

BBIO vs NTRS - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	BBIO	NTRS
2026	+5.83%	+33.60%
2025	+171.24%	+36.23%
2024	-32.16%	+24.92%
2023	+463.04%	-2.39%
2022	-55.59%	-24.51%
2021	-73.79%	+32.55%
2020	+114.06%	-10.25%
2019	+27.22%	+29.86%
2018	N/A	-14.31%
2017	N/A	+13.41%
2016	N/A	+28.77%
2015	N/A	+8.83%
2014	N/A	+12.92%
2013	N/A	+22.10%
2012	N/A	+26.63%
2011	N/A	-27.24%
2010	N/A	+7.82%
2009	N/A	+0.61%
2008	N/A	-28.41%
2007	N/A	+26.89%
2006	N/A	+18.00%
2005	N/A	+11.22%
2004	N/A	+7.00%
2003	N/A	+29.21%
2002	N/A	-40.27%
2001	N/A	-24.00%
2000	N/A	+62.85%
1999	N/A	+9.29%

BBIO vs NTRS Drawdown Comparison

The maximum drawdown for BBIO was -92.80%, occurring on May 11, 2022. Recovery took 1211 trading sessions.

The maximum drawdown for NTRS was -67.67%, occurring on Mar 11, 2003. Recovery took 1913 trading sessions.

The current BBIO drawdown is -8.17%. The current NTRS drawdown is -3.65%.

Rank	BBIO	NTRS
#1	-92.80% Feb 8, 2021 - Dec 3, 2025	-67.67% Dec 7, 2000 - Jul 22, 2008
#2	-65.45% Dec 23, 2019 - Nov 24, 2020	-60.45% Sep 11, 2008 - May 18, 2015
#3	-44.53% Sep 3, 2019 - Nov 20, 2019	-50.00% Jan 14, 2022 - Jun 23, 2025
#4	-21.99% Dec 31, 2020 - Feb 8, 2021	-42.75% Dec 12, 2019 - Mar 26, 2021
#5	-20.25% Jan 22, 2026 - Jul 9, 2026	-30.01% Jul 16, 2015 - Nov 9, 2016
#6	-16.79% Nov 22, 2019 - Dec 9, 2019	-29.98% Jul 24, 2018 - Dec 6, 2019
#7	-14.67% Jul 22, 2019 - Aug 26, 2019	-21.14% Mar 22, 2000 - Jul 14, 2000
#8	-12.87% Jul 11, 2019 - Jul 22, 2019	-18.83% Sep 12, 2000 - Dec 7, 2000
#9	-11.32% Jul 9, 2026 - Aug 3, 2026	-13.51% Feb 1, 2000 - Mar 16, 2000
#10	-6.70% Dec 12, 2019 - Dec 18, 2019	-13.12% Aug 27, 2021 - Oct 15, 2021
#11	-6.15% Jan 2, 2026 - Jan 13, 2026	-12.37% Feb 9, 2026 - Apr 13, 2026
#12	-5.62% Jul 5, 2019 - Jul 11, 2019	-12.34% Dec 30, 1999 - Jan 13, 2000
#13	-5.28% Aug 27, 2019 - Sep 3, 2019	-12.18% Jul 5, 2017 - Dec 4, 2017
#14	-4.46% Dec 1, 2020 - Dec 4, 2020	-10.61% Jun 1, 2021 - Aug 27, 2021
#15	-4.45% Dec 18, 2019 - Dec 20, 2019	-10.45% Jan 22, 2018 - Feb 26, 2018